Department of Surgery, Institute for the Treatment of Esophageal and Thoracic Disease, The Western Pennsylvania Hospital, Allegheny Health Network, 4600 Friendship Avenue, Suite 4800, Pittsburgh, PA 15224, USA.
Thorac Surg Clin. 2013 Nov;23(4):471-8. doi: 10.1016/j.thorsurg.2013.07.001.
Management of esophageal cancer starts with accurate tissue diagnosis and clinical staging. Advances in screening and surveillance programs and endoscopic techniques have resulted in patients with early-stage esophageal cancer diagnosed more frequently. Endoscopic mucosal resection for staging is essential to diagnose T1a cancer and crucial to exclude risk factors for progression to cancer or presence of concomitant cancer. Esophagectomy is an essential component of treatment of locally advanced, resectable esophageal cancer. Despite intensive multidisciplinary approaches, the prognosis of esophageal cancer is unacceptable. This article focuses on the process of decision making used to select optimal therapy for esophageal cancer.
食管癌的治疗始于准确的组织诊断和临床分期。筛查和监测计划以及内镜技术的进步使更多的早期食管癌患者得到诊断。内镜黏膜切除术对分期至关重要，可用于诊断 T1a 期癌症，并有助于排除进展为癌症或同时存在癌症的危险因素。食管癌根治术是局部进展期可切除食管癌治疗的重要组成部分。尽管采用了强化多学科方法，但食管癌的预后仍不理想。本文重点介绍了用于选择食管癌最佳治疗方案的决策过程。
